- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-635/20: Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE) (EU trade mark — Invalidity proceedings — EU word mark JUVÉDERM VYBRANCE — Late payment of the appeal fee — Inadmissibility of the appeal before the Board of Appeal — Article 101(4) of Regulation (EU) 2017/1001 — Article 106(1)(b) of Regulation 2017/1001 — Restitutio in integrum)
ECLI:EU:UNKNOWN:62020TA0635
62020TA0635
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
29.11.2021
Official Journal of the European Union
C 481/27
(Case T-635/20) (*)
(EU trade mark - Invalidity proceedings - EU word mark JUVÉDERM VYBRANCE - Late payment of the appeal fee - Inadmissibility of the appeal before the Board of Appeal - Article 101(4) of Regulation (EU) 2017/1001 - Article 106(1)(b) of Regulation 2017/1001 - Restitutio in integrum)
(2021/C 481/38)
Language of the case: English
Parties
Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO: Allergan Holdings France SAS (Courbevoie, France)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 24 August 2020 (Case R 1014/2020-4), relating to invalidity proceedings between Dermavita Company and Allergan Holdings France.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Dermavita Company S.a.r.l. to pay the costs.
(*)
Language of the case: English.
ECLI:EU:C:2021:140
* * *
(*) Language of the case: English.